Approval · Notice of Compliance 24824 · 2020
BUSPIRONE: Notice of Compliance 24824
Issued December 18, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24824
- Date
- December 18, 2020
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Updates to the product monograph. change in product ownership
Products in this notice
Medicinal ingredients
- BUSPIRONE HCL 5 MG per TAB
- BUSPIRONE HCL 10 MG per TAB